Long-term efficacy and safety of elamipretide in patients with Barth syndrome: 168-week open-label extension results of TAZPOWER
William Thompson, Ryan Manuel, Anthony Abbruscato, Jim Carr, John Campbell, Brittany Hornby, Frédéric M. Vaz, Hilary J. Vernon
Topics & Concepts
Open labelTerm (time)Extension (predicate logic)MedicinePediatricsInternal medicineAdverse effectComputer sciencePhysicsProgramming languageQuantum mechanicsCardiac electrophysiology and arrhythmiasMitochondrial Function and PathologyIon channel regulation and function